TC BioPharm (Holdings) plc Quarterly Retained Earnings (Accumulated Deficit) in GBP from Q4 2022 to Q1 2024

Taxonomy & unit
us-gaap: GBP
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
TC BioPharm (Holdings) plc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2022 to Q1 2024.
  • TC BioPharm (Holdings) plc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -£42.2M.
Retained Earnings (Accumulated Deficit), Quarterly (GBP)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -42.2M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -38.8M -5.46M -16.4% Dec 31, 2023 10-Q 2024-05-15
Q4 2022 -33.4M Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.